Center for the Prevention and Diagnosis of Celiac Disease, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Gastroenterology and Endoscopy Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Center for the Prevention and Diagnosis of Celiac Disease, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Gastroenterology and Endoscopy Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Clin Gastroenterol Hepatol. 2022 Apr;20(4):941-949.e3. doi: 10.1016/j.cgh.2020.11.010. Epub 2020 Nov 13.
BACKGROUND & AIMS: Complicated celiac disease (CCD) is a rare but severe condition with a poor prognosis. Guidelines recommend use of capsule endoscopy (CE) to explore the small bowel (SB), followed by a double-balloon enteroscopy (DBE) in selected cases with suspected CCD. Our study aimed to evaluate the diagnostic yield (DY) of CE and DBE in identifying and monitoring CCD.
Consecutive suspected CCD patients were enrolled prospectively to undergo CE and/or DBE in the presence of: persistent symptoms despite a correct gluten-free diet (GFD), increased anti-transglutaminase antibodies titer, lack of adherence to the GFD, and CCD monitoring. The DY of CE and DBE were calculated. The incidence of neoplastic complications and mortality were assessed.
In total, 130 patients (97 women; age, 49 ± 16 y) underwent 151 CEs and 23 DBEs. The DY of CE was 46%. Patients older than age 50 years (at CE examination or at CD diagnosis) with a CD duration shorter than 5 years were at higher risk of positive CE (relative risk, 1.6 and 1.7 in case of enrollement or CD diagnosis after 50 years of age, and 1.5 in case of short CD duration; P < .05) than their counterparts. Up to 40% of SB lesions were unreachable by upper endoscopy. At the end of the diagnostic work-up, 25 patients with premalignant/malignant lesions were identified: 12 type 1 refractory CD (RCD-1), 7 type 2 RCD (RCD-2), and 6 enteropathy-associated T-cell lymphoma (EATL). Six patients died: 2 patients with RCD-2 and 4 patients with EATL.
In case of suspected CCD, CE should be the first-line approach to detect complications and to identify patients deserving DBE. Older and symptomatic patients with suspected CCD deserve a careful evaluation of the SB, especially during the first years after diagnosis.
复杂型乳糜泻(CCD)是一种罕见但严重的疾病,预后不良。指南建议使用胶囊内镜(CE)探查小肠(SB),然后在疑似 CCD 的情况下选择性使用双气囊内镜(DBE)。本研究旨在评估 CE 和 DBE 在识别和监测 CCD 方面的诊断收益(DY)。
连续纳入疑似 CCD 患者,前瞻性地进行 CE 和/或 DBE,适应证包括:尽管进行了无麸质饮食(GFD),但仍持续存在症状、抗转谷氨酰胺酶抗体滴度增加、未遵守 GFD 以及 CCD 监测。计算 CE 和 DBE 的 DY。评估肿瘤并发症和死亡率的发生率。
共有 130 名患者(97 名女性;年龄 49 ± 16 岁)接受了 151 次 CE 和 23 次 DBE。CE 的 DY 为 46%。在 CE 检查或 CD 诊断时年龄大于 50 岁的患者,或 CD 病程短于 5 年的患者,CE 阳性的风险更高(相对风险分别为 1.6 和 1.7,如果在 50 岁后入组或诊断为 CD,以及 CD 病程较短;P<0.05)。高达 40%的 SB 病变无法通过上消化道内镜到达。在诊断性检查结束时,发现 25 例有癌前/恶性病变的患者:12 例 1 型难治性 CD(RCD-1),7 例 2 型 RCD(RCD-2)和 6 例肠病相关 T 细胞淋巴瘤(EATL)。6 例患者死亡:2 例 RCD-2 和 4 例 EATL。
疑似 CCD 时,CE 应作为检测并发症和识别需要 DBE 的患者的一线方法。疑似 CCD 的老年和有症状患者需要仔细评估 SB,尤其是在诊断后最初几年。